Enovix is trading at $2.23, down 5.11%, as the October 20 decline remains unexplained by available company or market context.

  • The Northland price-target cut was reported about a week earlier and does not establish the cause.
  • Technology shares were broadly stronger, and available evidence does not show Enovix moving with the sector.